Biotech dealmaking is on pace for a bumper year in 2026, with large drugmakers on an acquisition spree to boost their ...

A veteran of Pfizer, Sanofi, and Novo Nordisk who built patient access programmes across West Africa argues that the $500 billion medication adherence crisis plaguing American healthcare has already ...

Add us on Google In 1850, if you had a fever, you visited an apothecary. They were masters of bespoke creation. They didn’t ...

Handheld devices and personal computers have revolutionised the way we operate and communicate. These developments are thanks ...

UC San Diego researchers have developed T1GRS, a machine‑learning model that accurately predicts genetic risk for Type 1 ...

Foundayo became available on April 9 and has already reached 20,000 patients as Eli Lilly builds its marketing machine for ...

ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing in ...

These developments are thanks to the work of early programming pioneers, such as Priscilla Fuller. See is seen here with ...

Massive Bio, a leader in AI-enabled patient recruitment and oncology solutions, today announced a collaboration with OpenAI to advance clinical trial accessibility through large-scale parameterization ...

At a Reuters conference earlier this year, Johnson & Johnson chief information officer Jim Swanson offered a striking number: ...

Ireland has evolved into one of the world’s most critical locations for the global Pharmaceutical Industry. Today, with more ...

VIAVI Solutions Inc. (VIAVI) today announced investment in its new PCIe® 7.0 protocol analysis testing platform which will include analyzers, exercisers and high-performance interposers from the VIAVI ...